Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

Zacks #1 Stocks on the Move 05/20/2013

Company Name Symbol %Change
NOAH HOLDING NOAH
12.77%
EAGLE BULK S EGLE
9.80%
ORBOTECH LTD ORBK
9.10%
VIPSHOP HOLD VIPS
8.92%
RENEWABLE EN REGI
7.28%
Zacks ZACKS.COM
PROFIT from the PROS

Tactics that Work in Good Markets and Bad
 
--

Flirting With a Breakout

As I shared in recent commentary, the market has been trading in a clear range since early August. The downside support is 1100 and the upside resistance is 1265 (where the 200 day moving average sits). Monday we flirted just above that line for a while before settling in a notch below at 1257 (which is where the year started).

The catalyst for these gains is growing expectations of success in the Eurozone. Many are predicting a "Shock and Awe" barrage of new strategies this week coming into the European Summit on Friday to help contain their debt crisis.

I too think the odds are fairly good of them impressing investors this week leading to a breakout to the upside. However, if they stumble, then we will fall 5%+ in no time at all. Place your trades accordingly.

Featured Commentaries on Zacks.com
•  4 Stocks with Large Insider Ownership
•  Roundtable Stock Picks
•  Highest-Yielding Int'l Bond Mutual Funds

Best,

Steve Reitmeister
Executive VP, Zacks Investment Research

 

Sponsor

What Obama Can't Do, These SIX Events Could

I urge you, watch this eye-opening video presentation and find out WHICH six "jackpot" events are about to change your life...

And could even make you richer, healthier and happier... in ways no politician ever could!

Click here and find about the SIX EVENTS about to change your life forever.

 

Today's Top Stories: Tuesday- December 06, 2011

ZACKS RANK BUY STOCKS

Learn how to profit from our exclusive Zacks Rank stock-ranking system with free resources. Read More...

 

ZACKS MUTUAL FUND RANK

BEST OF ZACKS EQUITY RESEARCH

 

Sponsor

New Report: Biotech Revolution Imminent...


A small biotech in California is about to change the course of medical history forever. The CDC calls this technology "the next evolution in medical treatments." The U.S. Health Dept. says, "We're on the cusp of a worldwide explosion" and this firm is a catalyst.


Click here to get a FREE investor report on this early opportunity.

 

NEW ZACKS VIDEOS:

PeopleAndPicks.com:

VIP "InvestmentMAGE" continues to bring in positive returns with his BUY calls in (INCY), (PERY) and (TX). Read More...

EARNINGS PREVIEW Look to the Other Side of the Pond

It will be a light week for both earnings and Data, so the market will probably take its clues from events in Europe. Read More...

EARNINGS TRENDS: Wrapping Up 3Q Earnings

The third quarter reports are almost done. So far 496 or 99.2% of reports are in. Read More...

 

BEST OF ZACKS.COM PARTNER COMMENTARY

FACEBOOK

Visit the Zacks.com Facebook page and get the latest insight on stocks and the market:
Zacks On Facebook

TWITTER

Get the Zacks.com newsfeed delivered straight to your Twitter account:
Zacks On Twitter

OTHER ZACKS RESOURCES:

 

Manage your Profit from the Pros subscription:

REFER-A-FRIEND

If you enjoy this e-mail newsletter, then please pass it along to a friend. Simply forward them the link below to sign up for their own free subscription. THANKS!
Refer a Friend

Best,

Steve Reitmeister
Executive VP, Zacks Investment Research

p.s. What is the mission for Zacks Profit from the Pros? To find out how we will help you become a more successful investor, click here.

Visit /performance for information about the performance numbers displayed in this newsletter.

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

To contact us by mail:

Zacks Investment Research
Attn: Profit from the Pros
111 N. Canal St., Suite 1101
Chicago, IL 60606

To unsubscribe from receiving "Zacks.com Profit from the Pros"
e-mail newsletter, Click here....

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.